share_log
Breakings ·  Nov 25, 2024 20:40
Biohaven Shares Fall 12.3% Premarket as Sma Treatment Did Not Show Statistically Significant Difference on Primary Outcome in Trial
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment